OPKO HEALTH INC COM USD0.01OPKO HEALTH INC COM USD0.01OPKO HEALTH INC COM USD0.01

OPKO HEALTH INC COM USD0.01

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.08 B‬USD
−0.1832USD
‪−188.86 M‬USD
‪863.50 M‬USD
‪318.10 M‬
Beta (1Y)
0.85
Employees (FY)
‪3.93 K‬
Change (1Y)
−266 −6.34%
Revenue / Employee (1Y)
‪219.72 K‬USD
Net income / Employee (1Y)
‪−48.06 K‬USD

About Opko Health, Inc.


CEO
Phillip Frost
Website
Headquarters
Miami
Founded
1991
FIGI
BBG00JVRGJR6
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
OPK4795151
OPKO Health, Inc. 4.5% 15-FEB-2025
Yield to maturity
31.77%
Maturity date
Feb 15, 2025
OPK4020628
OPKO Health, Inc. 3.0% 01-FEB-2033
Yield to maturity
Maturity date
Feb 1, 2033
OPK4048118
OPKO Health, Inc. 3.0% 01-FEB-2033
Yield to maturity
Maturity date
Feb 1, 2033
OPK5733212
OPKO Health, Inc. 3.75% 15-JAN-2029
Yield to maturity
Maturity date
Jan 15, 2029

Explore more bonds 

Frequently Asked Questions


The current price of 0KCS is 1.5694 USD — it hasn't changed in the past 24 hours. Watch OPKO HEALTH INC COM USD0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange OPKO HEALTH INC COM USD0.01 stocks are traded under the ticker 0KCS.
0KCS stock has fallen by −1.91% compared to the previous week, the month change is a 7.49% rise, over the last year OPKO HEALTH INC COM USD0.01 has showed a 2.61% increase.
We've gathered analysts' opinions on OPKO HEALTH INC COM USD0.01 future price: according to them, 0KCS price has a max estimate of 8.50 USD and a min estimate of 2.00 USD. Watch 0KCS chart and read a more detailed OPKO HEALTH INC COM USD0.01 stock forecast: see what analysts think of OPKO HEALTH INC COM USD0.01 and suggest that you do with its stocks.
0KCS reached its all-time high on Feb 1, 2021 with the price of 6.0850 USD, and its all-time low was 0.8516 USD and was reached on Jan 5, 2024. View more price dynamics on 0KCS chart.
See other stocks reaching their highest and lowest prices.
0KCS stock is 1.90% volatile and has beta coefficient of 0.85. Track OPKO HEALTH INC COM USD0.01 stock price on the chart and check out the list of the most volatile stocks — is OPKO HEALTH INC COM USD0.01 there?
Today OPKO HEALTH INC COM USD0.01 has the market capitalization of ‪1.08 B‬, it has decreased by −4.88% over the last week.
Yes, you can track OPKO HEALTH INC COM USD0.01 financials in yearly and quarterly reports right on TradingView.
OPKO HEALTH INC COM USD0.01 is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
0KCS earnings for the last quarter are 0.03 USD per share, whereas the estimation was −0.09 USD resulting in a 132.14% surprise. The estimated earnings for the next quarter are −0.08 USD per share. See more details about OPKO HEALTH INC COM USD0.01 earnings.
OPKO HEALTH INC COM USD0.01 revenue for the last quarter amounts to ‪173.60 M‬ USD, despite the estimated figure of ‪181.52 M‬ USD. In the next quarter, revenue is expected to reach ‪155.42 M‬ USD.
0KCS net income for the last quarter is ‪24.89 M‬ USD, while the quarter before that showed ‪−10.30 M‬ USD of net income which accounts for 341.53% change. Track more OPKO HEALTH INC COM USD0.01 financial stats to get the full picture.
No, 0KCS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has ‪3.93 K‬ employees. See our rating of the largest employees — is OPKO HEALTH INC COM USD0.01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OPKO HEALTH INC COM USD0.01 EBITDA is ‪−209.40 M‬ USD, and current EBITDA margin is −6.11%. See more stats in OPKO HEALTH INC COM USD0.01 financial statements.
Like other stocks, 0KCS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPKO HEALTH INC COM USD0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OPKO HEALTH INC COM USD0.01 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OPKO HEALTH INC COM USD0.01 stock shows the buy signal. See more of OPKO HEALTH INC COM USD0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.